RecruitingPhase not listed

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

Multi-Institution Registry of SRS/SBRT Procedures

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
No age limits stated
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This long-term study tracks the use and results of SRS/SBRT, treatments that aim radiation at a small area of the body. It is for people with tumors or other conditions that can be treated this way. The goal is to learn how best to use these treatments over time.

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Have a tumor, with or without cancer, or another condition that can be treated with SRS/SBRT.
  • Be willing to sign a consent form or agree out loud to take part.

Who can't join

  • There are no specific medical reasons listed that would keep someone out.
  • People who will not give consent or who choose not to take part will not be included.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy * Willingness to sign an Informed Consent Document or verbally agree to participation Exclusion Criteria: * There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included

Study sites (13)

CO

FL

  • Sylvester Comprehensive Cancer Center, University of Miami · Miami, FL 33146Gregory A Azzam, MD · Study contact · gxa338@med.miami.eduGregory A Azzam, MD · Principal investigatorMore trials in Miami

GA

MI

NJ

NY

PA

TN

WV